E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim

E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim

Background: Dihydrofolate reductase (DHFR) (dfrA gene) is an essential enzyme for cell survival and an unexplored target in Mycobacterium tuberculosis (Mtb). This study was carried out to analyze mutations in the dfrA gene amongst 20 clinical DNA samples from Mtb isolates obtained from Mumbai, India...

Full description

Bibliographic Details
Main Authors: Archana Raju, Savita Kulkarni, M K Ray, M G.R Rajan, Mariam S Degani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:International Journal of Mycobacteriology
Subjects:
Mycobacterium tuberculosis
Dihydrofolate reductase
Point mutation
Molecular docking
Enzyme assay
Trimethoprim
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=2;spage=97;epage=103;aulast=Raju

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=2;spage=97;epage=103;aulast=Raju

Similar Items